{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:13:30Z","timestamp":1788189210740,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82474262"],"award-info":[{"award-number":["82474262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515011748"],"award-info":[{"award-number":["2024A1515011748"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZZYSM202206014"],"award-info":[{"award-number":["SZZYSM202206014"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Project for the Development of Key Specialties in Chinese Medicine","award":["900"],"award-info":[{"award-number":["900"]}]},{"name":"Shenzhen Bao\u2019an District Key Medical Discipline Development Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-67064-1","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:45:44Z","timestamp":1786956344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based mapping of multimodal treatment allocations and prognostic implications of clinical concordance in non-small cell lung cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Haozhu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"67064_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"67064_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri, A. et al. Lung cancer immunotherapy: Progress, pitfalls, and promises. Mol. Cancer 22, 40. https:\/\/doi.org\/10.1186\/s12943-023-01740-y (2023).","journal-title":"Mol. Cancer"},{"key":"67064_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12885-024-11875-w","volume":"24","author":"JS Liu","year":"2024","unstructured":"Liu, J. S. et al. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC. BMC Cancer 24, 123. https:\/\/doi.org\/10.1186\/s12885-024-11875-w (2024).","journal-title":"BMC Cancer"},{"key":"67064_CR4","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","volume":"188","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. Cell 188, 3081-3096.e3019. https:\/\/doi.org\/10.1016\/j.cell.2025.03.018 (2025).","journal-title":"Cell"},{"key":"67064_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/s0140-6736(24)00814-6","volume":"404","author":"A Kr\u00e4mer","year":"2024","unstructured":"Kr\u00e4mer, A. et al. Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): An open-label, randomised, phase 2 study. Lancet 404, 527\u2013539. https:\/\/doi.org\/10.1016\/s0140-6736(24)00814-6 (2024).","journal-title":"Lancet"},{"key":"67064_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/s0140-6736(23)02268-7","volume":"403","author":"JS Weber","year":"2024","unstructured":"Weber, J. S. et al. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): A randomised, phase 2b study. Lancet 403, 632\u2013644. https:\/\/doi.org\/10.1016\/s0140-6736(23)02268-7 (2024).","journal-title":"Lancet"},{"key":"67064_CR7","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jamia\/ocae088","volume":"31","author":"FS Bashiri","year":"2024","unstructured":"Bashiri, F. S. et al. Development and external validation of deep learning clinical prediction models using variable-length time series data. J. Am. Med. Inform. Assoc. 31, 1322\u20131330. https:\/\/doi.org\/10.1093\/jamia\/ocae088 (2024).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"67064_CR8","doi-asserted-by":"publisher","DOI":"10.2196\/65898","volume":"8","author":"Y Hashimoto","year":"2025","unstructured":"Hashimoto, Y., Inoue, N., Tani, T. & Imai, S. Machine learning for predicting postoperative functional disability and mortality among older patients with cancer: Retrospective cohort study. JMIR Aging 8, e65898. https:\/\/doi.org\/10.2196\/65898 (2025).","journal-title":"JMIR Aging"},{"key":"67064_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12931-024-02839-6","volume":"25","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Machine-learning developed an iron, copper, and sulfur-metabolism associated signature predicts lung adenocarcinoma prognosis and therapy response. Respir. Res. 25, 206. https:\/\/doi.org\/10.1186\/s12931-024-02839-6 (2024).","journal-title":"Respir. Res."},{"key":"67064_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41746-023-00976-8","volume":"7","author":"KH Lee","year":"2024","unstructured":"Lee, K. H. et al. Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: A multi-center study. NPJ Digit. Med. 7, 2. https:\/\/doi.org\/10.1038\/s41746-023-00976-8 (2024).","journal-title":"NPJ Digit. Med."},{"key":"67064_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117784","volume":"245","author":"D Wu","year":"2024","unstructured":"Wu, D. et al. Utilizing nanotechnology and advanced machine learning for early detection of gastric cancer surgery. Environ. Res. 245, 117784. https:\/\/doi.org\/10.1016\/j.envres.2023.117784 (2024).","journal-title":"Environ. Res."},{"key":"67064_CR12","doi-asserted-by":"publisher","first-page":"1656191","DOI":"10.3389\/fendo.2025.1656191","volume":"16","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. Machine learning algorithms for individualized prediction of prognosis in breast cancer liver metastases and the prognostic impact of primary tumor surgery: A multicenter study. Front Endocrinol. Lausanne 16, 1656191. https:\/\/doi.org\/10.3389\/fendo.2025.1656191 (2025).","journal-title":"Front Endocrinol. Lausanne"},{"key":"67064_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2025.106160","volume":"206","author":"Q Luo","year":"2026","unstructured":"Luo, Q., Zheng, Z., Luo, W. & Zhu, J. Development and external validation of interpretable machine learning models for personalized multiple treatment recommendations in non-small cell lung cancer. Int. J. Med. Inform. 206, 106160. https:\/\/doi.org\/10.1016\/j.ijmedinf.2025.106160 (2026).","journal-title":"Int. J. Med. Inform."},{"key":"67064_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/life15111742","author":"C Montalvo-Pacheco","year":"2025","unstructured":"Montalvo-Pacheco, C. et al. Disparities in colorectal cancer mortality and survival trends among hispanics living in Puerto Rico (2000\u20132021): A comparison between early-onset and average-onset disease. Life (Basel) https:\/\/doi.org\/10.3390\/life15111742 (2025).","journal-title":"Life (Basel)"},{"key":"67064_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108516","volume":"50","author":"X Peng","year":"2024","unstructured":"Peng, X. & Liu, J. The relationship between household income and prognosis of patients with cervical adenocarcinoma in the United States: A retrospective cohort study based on the SEER database. Eur. J. Surg. Oncol. 50, 108516. https:\/\/doi.org\/10.1016\/j.ejso.2024.108516 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"key":"67064_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378. https:\/\/doi.org\/10.1136\/bmj-2023-078378 (2024).","journal-title":"BMJ"},{"key":"67064_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2021.104510","volume":"153","author":"F Cabitza","year":"2021","unstructured":"Cabitza, F. & Campagner, A. The need to separate the wheat from the chaff in medical informatics: Introducing a comprehensive checklist for the (self)-assessment of medical AI studies. Int. J. Med. Inform. 153, 104510. https:\/\/doi.org\/10.1016\/j.ijmedinf.2021.104510 (2021).","journal-title":"Int. J. Med. Inform."},{"key":"67064_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely, G. J. et al. Non-small cell lung cancer, Version 4.2024, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 22, 249\u2013274. https:\/\/doi.org\/10.6004\/jnccn.2204.0023 (2024).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"67064_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.chest.2025.06.023","volume":"168","author":"J Howington","year":"2025","unstructured":"Howington, J. et al. Management of patients with early-stage non-small cell lung cancer: An American College of Chest Physicians Clinical Practice Guideline. Chest 168, 810\u2013827. https:\/\/doi.org\/10.1016\/j.chest.2025.06.023 (2025).","journal-title":"Chest"},{"key":"67064_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00262-024-03696-4","volume":"73","author":"S Guan","year":"2024","unstructured":"Guan, S. et al. Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: A real-world multicenter retrospective study. Cancer Immunol. Immunother. 73, 120. https:\/\/doi.org\/10.1007\/s00262-024-03696-4 (2024).","journal-title":"Cancer Immunol. Immunother."},{"key":"67064_CR21","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1200\/jco.22.02544","volume":"41","author":"GV Scagliotti","year":"2023","unstructured":"Scagliotti, G. V. et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J. Clin. Oncol. 41, 2458\u20132466. https:\/\/doi.org\/10.1200\/jco.22.02544 (2023).","journal-title":"J. Clin. Oncol."},{"key":"67064_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.athoracsur.2024.09.041","volume":"119","author":"SS Kim","year":"2025","unstructured":"Kim, S. S. et al. The Society of Thoracic Surgeons Expert Consensus on the multidisciplinary management and resectability of locally advanced non-small cell lung cancer. Ann. Thorac. Surg. 119, 16\u201333. https:\/\/doi.org\/10.1016\/j.athoracsur.2024.09.041 (2025).","journal-title":"Ann. Thorac. Surg."},{"key":"67064_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.21037\/tlcr-24-974","volume":"14","author":"H Zhu","year":"2025","unstructured":"Zhu, H. et al. Multidisciplinary management of N2 stage III non-small cell lung cancer: Opportunities and challenges for radiation oncology. Transl. Lung Cancer Res. 14, 991\u20131006. https:\/\/doi.org\/10.21037\/tlcr-24-974 (2025).","journal-title":"Transl. Lung Cancer Res."},{"key":"67064_CR24","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.3390\/curroncol30030239","volume":"30","author":"F Petrella","year":"2023","unstructured":"Petrella, F. et al. Stage III non-small-cell lung cancer: An overview of treatment options. Curr. Oncol. 30, 3160\u20133175. https:\/\/doi.org\/10.3390\/curroncol30030239 (2023).","journal-title":"Curr. Oncol."},{"key":"67064_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3779\/j.issn.1009-3419.2020.101.06","volume":"23","author":"X Guo","year":"2020","unstructured":"Guo, X., Wang, H. & Wei, Y. Pneumonectomy for non-small cell lung cancer: Predictors of operative mortality and survival. Zhongguo Fei Ai Za Zhi 23, 573\u2013581. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2020.101.06 (2020).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"67064_CR26","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/1759-7714.14904","volume":"14","author":"M Shimokawa","year":"2023","unstructured":"Shimokawa, M. et al. Clinical benefit of platinum doublet combination therapy in older adults with advanced non-small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan. Thorac. Cancer 14, 1597\u20131605. https:\/\/doi.org\/10.1111\/1759-7714.14904 (2023).","journal-title":"Thorac. Cancer"},{"key":"67064_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101374","volume":"12","author":"Y Shen","year":"2025","unstructured":"Shen, Y., Chen, J. Q. & Li, X. P. Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy. Genes Dis. 12, 101374. https:\/\/doi.org\/10.1016\/j.gendis.2024.101374 (2025).","journal-title":"Genes Dis."},{"key":"67064_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jjco\/hyae049","volume":"54","author":"Y Izaki","year":"2024","unstructured":"Izaki, Y. et al. Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma. Jpn. J. Clin. Oncol. 54, 813\u2013821. https:\/\/doi.org\/10.1093\/jjco\/hyae049 (2024).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"67064_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11813","volume":"4","author":"ZH Chen","year":"2021","unstructured":"Chen, Z. H. et al. Assessment of modifiable factors for the association of marital status with cancer-specific survival. JAMA Netw. Open 4, e2111813. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.11813 (2021).","journal-title":"JAMA Netw. Open"},{"key":"67064_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjon.2025.101544","volume":"29","author":"S Sakowitz","year":"2026","unstructured":"Sakowitz, S., Bakhtiyar, S. S., Sanaiha, Y., Ali, K. & Benharash, P. National race-based disparities in referral to Commission on Cancer centers for lung cancer resection. JTCVS Open 29, 101544. https:\/\/doi.org\/10.1016\/j.xjon.2025.101544 (2026).","journal-title":"JTCVS Open"},{"key":"67064_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6921","volume":"13","author":"Q Fan","year":"2024","unstructured":"Fan, Q. et al. Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States. Cancer Med. 13, e6921. https:\/\/doi.org\/10.1002\/cam4.6921 (2024).","journal-title":"Cancer Med."},{"key":"67064_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jss.2022.10.097","volume":"283","author":"CD Logan","year":"2023","unstructured":"Logan, C. D. et al. Rural-urban disparities in receipt of surgery for potentially resectable non-small cell lung cancer. J. Surg. Res. 283, 1053\u20131063. https:\/\/doi.org\/10.1016\/j.jss.2022.10.097 (2023).","journal-title":"J. Surg. Res."},{"key":"67064_CR33","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.21037\/tlcr.2019.05.06","volume":"8","author":"V Jairam","year":"2019","unstructured":"Jairam, V. & Park, H. S. Strengths and limitations of large databases in lung cancer radiation oncology research. Transl. Lung Cancer Res. 8, S172-s183. https:\/\/doi.org\/10.21037\/tlcr.2019.05.06 (2019).","journal-title":"Transl. Lung Cancer Res."},{"key":"67064_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13014-020-1466-y","volume":"15","author":"S Moore","year":"2020","unstructured":"Moore, S., Leung, B., Wu, J. & Ho, C. Population-based analysis of curative therapies in stage II non-small cell lung cancer: The role of radiotherapy in medically inoperable patients. Radiat. Oncol. 15, 23. https:\/\/doi.org\/10.1186\/s13014-020-1466-y (2020).","journal-title":"Radiat. Oncol."},{"key":"67064_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.835844","volume":"12","author":"I Fornacon-Wood","year":"2022","unstructured":"Fornacon-Wood, I. et al. Impact of introducing intensity modulated radiotherapy on curative intent radiotherapy and survival for lung cancer. Front. Oncol. 12, 835844. https:\/\/doi.org\/10.3389\/fonc.2022.835844 (2022).","journal-title":"Front. Oncol."},{"key":"67064_CR36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/s1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez, D. R. et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 17, 1672\u20131682. https:\/\/doi.org\/10.1016\/s1470-2045(16)30532-0 (2016).","journal-title":"Lancet Oncol."},{"key":"67064_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2478\/raon-2022-0030","volume":"56","author":"M Bitenc","year":"2022","unstructured":"Bitenc, M. et al. Real-life long-term outcomes of upfront surgery in patients with resectable stage I-IIIA non-small cell lung cancer. Radiol. Oncol. 56, 346\u2013354. https:\/\/doi.org\/10.2478\/raon-2022-0030 (2022).","journal-title":"Radiol. Oncol."},{"key":"67064_CR38","doi-asserted-by":"publisher","first-page":"29441","DOI":"10.1038\/s41598-024-79158-9","volume":"14","author":"PC Hu","year":"2024","unstructured":"Hu, P. C. et al. Trimodal therapy and surgical approaches in stage IIIA\/N2 non-small cell lung cancer. Sci. Rep. 14, 29441. https:\/\/doi.org\/10.1038\/s41598-024-79158-9 (2024).","journal-title":"Sci. Rep."},{"key":"67064_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamaoncol.2024.0057","volume":"10","author":"M Sorin","year":"2024","unstructured":"Sorin, M. et al. Neoadjuvant chemoimmunotherapy for NSCLC: A systematic review and meta-analysis. JAMA Oncol. 10, 621\u2013633. https:\/\/doi.org\/10.1001\/jamaoncol.2024.0057 (2024).","journal-title":"JAMA Oncol."},{"key":"67064_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100979","volume":"50","author":"MQ Jiang","year":"2024","unstructured":"Jiang, M. Q. et al. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection. Neoplasia 50, 100979. https:\/\/doi.org\/10.1016\/j.neo.2024.100979 (2024).","journal-title":"Neoplasia"},{"key":"67064_CR41","doi-asserted-by":"publisher","first-page":"25067","DOI":"10.1038\/s41598-025-10042-w","volume":"15","author":"L Sun","year":"2025","unstructured":"Sun, L. et al. In the context of the era of targeted therapy: evaluation of the survival benefits of different local treatment modalities for patients with 1\u20133 brain metastases from non-small cell lung cancer. Sci. Rep. 15, 25067. https:\/\/doi.org\/10.1038\/s41598-025-10042-w (2025).","journal-title":"Sci. Rep."},{"key":"67064_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaoncol.2021.7664","volume":"8","author":"AV Louie","year":"2022","unstructured":"Louie, A. V. et al. Palliative radiation for advanced central lung tumors with intentional avoidance of the esophagus (PROACTIVE): A phase 3 randomized clinical trial. JAMA Oncol. 8, 1\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2021.7664 (2022).","journal-title":"JAMA Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67064-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67064-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67064-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:16:24Z","timestamp":1788185784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67064-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67064"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-67064-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this population-based study were obtained from a publicly available, de-identified database (SEER). Therefore, institutional ethical approval and informed consent from patients were waived.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Gemini 3.1 Pro to improve the language and readability of the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":3,"name":"Ethics","label":"Declaration of generative AI use","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27265"}}